Chromosome centromere copy number amplification associated with exceptional response in HER2-positive metastatic breast cancer patients
Naomi Walsh(Dublin City University), John Crown(St. Vincent's University Hospital)
Cited by 0
Related Papers
MYC as a target for cancer treatment
|Cancer Treatment Reviews|2021|528
Effects of HER Family–targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer
|Clinical Cancer Research|2020|75
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma
|Journal of Clinical Oncology|2024|37
Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma
|International Journal of Oncology|2015|20
Prognostic Value of BAP1 Protein Expression in Uveal Melanoma
|The American Journal of Surgical Pathology|2024|18